Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study.
CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis: A Role in Immune Cells and Vascular Cells of the Blood-Brain Barrier.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Source of iron overload in multiple sclerosis.
A Friend in Need may not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis.
Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.
Tumefactive demyelination presenting during bevacizumab treatment.
Orbital and optic nerve complications of inflammatory bowel disease.
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.
A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms.
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.
Tetrahydrocannabinol for tremor in multiple sclerosis.
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Education attenuates the negative impact of traumatic brain injury on cognitive status.
Robust myelin quantitative imaging from multi-echo T2 MRI using edge preserving spatial priors.
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.
Neuromyelitis optica.
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis.
Effects of albendazole combined with TSII-A (a Chinese herb compound) on optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice.
Quality of life in patients with multiple sclerosis.
Footfall Placement Variability and Falls in Multiple Sclerosis.
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »